• This vaccine is recommended for everyone 50 years of age and older, however it is currently only publicly funded (free) in Ontario for adults aged 65-70 years. People wanting protection earlier than 65 years would need to purchase the vaccine through their local pharmacy. It may be covered by extended health plans.
• It is a 2-dose series (2-6 months between doses).
• It is recommended for:
• Adults ≥ 50 years without contraindications - the incidence and severity of shingles begins to increase with age beyond 50 years.
• Adults ≥ 50 years of age without contraindications who have previously been immunized with Zostavax® II, should be offered a 2-dose series of Shingrix®. Re-immunization with Shingrix® may be considered at least one year after Zostavax® II.
• Adults with history of shingles may have lower recurrence rates following vaccination. For this reason, Zos vaccine may be given to those over the age of 50 with a history of shingles. Clients should wait at least 1 year between their last episode of shingles and receiving the vaccine.
• Shingles vaccine should be administered to individuals eligible for the vaccine regardless of whether or not the person has a history of varicella (chickenpox) infection. Nearly all Canadians eligible for shingles vaccine will have had prior varicella exposure, even if a diagnosis of varicella cannot be recalled. Therefore, the vaccine should still be offered to individuals to protect against shingles.